• 1
    Sharpe, A. H. and Freeman, G. J., The B7-CD28 superfamily. Nat. Rev. Immunol. 2002. 2:116126.
  • 2
    Okazaki, T., Iwai, Y. and Honjo, T., New regulatory co-receptors: inducible co-stimulator and PD-1. Curr. Opin. Immunol. 2002. 14: 779782.
  • 3
    Dong, H. and Chen, L., B7-H1 pathway and its role in the evasion of tumor immunity. J. Mol. Med. 2003. 81: 281287.
  • 4
    Ishida, Y., Agata, Y., Shibahara, K. and Honjo, T., Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 1992. 11: 38873895.
  • 5
    Okazaki, T., Maeda, A., Nishimura, H., Kurosaki, T. and Honjo, T., PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc.Natl. Acad. Sci. USA 2001. 98: 1386613871.
  • 6
    Nishimura, H., Nose, M., Hiai, H., Minato, N. and Honjo, T., Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999. 11: 141151.
  • 7
    Dong, H., Zhu, G., Tamada, K. and Chen, L., B7-H1, a third member ofthe B7 family, co-stimulates T cell proliferation and interleukin-10 secretion. Nat. Med. 1999. 5: 13651369.
  • 8
    Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova,T., Nishimura, H., Fitz, L. J., Malenkovich, N., Okazaki, T., Byrne, M. C., Horton, H. F., Fouser, L., Carter, L., Ling, V., Bowman, M. R., Carreno, B. M., Collins, M., Wood, C. R. and Honjo, T., Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 2000. 192: 10271034.
  • 9
    Latchman, Y., Wood, C. R., Chernova, T., Chaudhary, D., Borde, M., Chernova, I., Iwai, Y., Long, A. J., Brown, J. A., Nunes, R., Greenfield, E. A., Bourque, K., Boussiotis, V. A., Carter, L. L., Carreno, B. M., Malenkovich, N., Nishimura, H., Okazaki, T., Honjo, T., Sharpe, A. H. and Freeman, G. J., PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2001. 2: 261268.
  • 10
    Tseng, S. Y., Otsuji, M., Gorski, K., Huang, X., Slansky, J. E., Pai, S. I., Shalabi, A., Shin, T., Pardoll, D. M. and Tsuchiya, H., B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J. Exp. Med. 2001. 193: 839846.
  • 11
    Bleul, C. C. and Boehm, T., Laser capture microdissection-based expression profiling identifies PD1-ligand as a target of the nude locus gene product. Eur. J. Immunol. 2001. 31: 24972503.
  • 12
    Agata, Y., Kawasaki, A., Nishimura, H., Ishida, Y., Tsubata,T., Yagita, H. and Honjo, T., Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int. Immunol. 1996. 8: 765772.
  • 13
    Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano,F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., Lennon, V. A., Celis, E. and Chen, L., Tumor-associated B7-H1 promotes T cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 2002. 8: 793800.
  • 14
    Atkinson, M. A. and Leiter, E. H., The NOD mouse model of type 1 diabetes: as good as it gets? Nat. Med. 1999. 5: 601604.
  • 15
    Delovitch, T. L. and Singh, B., The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 1997. 7: 727738.
  • 16
    Wang, B., Andre, I., Gonzalez, A., Katz, J. D., Aguet, M., Benoist, C. and Mathis, D., Interferon-gamma impacts at multiple points during the progression of autoimmune diabetes. Proc. Natl. Acad. Sci. USA 1997. 94: 1384413849.
  • 17
    Gonzalez, A., Katz, J. D., Mattei, M. G., Kikutani, H., Benoist, C. and Mathis, D., Genetic control of diabetes progression. Immunity 1997. 7: 873883.
  • 18
    Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., Zurawski, S., Wiekowski, M., Lira, S. A., Gorman, D., Kastelein, R. A. and Sedgwick, J. D., Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003. 421: 744748.
  • 19
    Kuchroo, V. K., Anderson, A. C., Waldner, H., Munder, M., Bettelli, E. and Nicholson, L. B., T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire. Annu. Rev. Immunol. 2002. 20: 101123.
  • 20
    Yamazaki, T., Akiba, H., Iwai, H., Matsuda, H., Aoki, M., Tanno, Y., Shin, T., Tsuchiya, H., Pardoll, D. M., Okumura, K., Azuma, M. and Yagita, H., Expression of programmed death 1 ligands by murine T cells and APC. J. Immunol. 2002. 169: 55385545.
  • 21
    Coyle, A. J. and Gutierrez-Ramos, J. C., The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function. Nat. Immunol. 2001. 2: 203209.
  • 22
    Kaplan, M. H., Sun, Y. L., Hoey, T. and Grusby, M. J., Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 1996. 382: 174177.
  • 23
    Kaplan, M. H., Schindler, U., Smiley, S. T. and Grusby, M. J., Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 1996. 4: 313319.
  • 24
    DiDonato, J. A., Hayakawa, M., Rothwarf, D. M., Zandi, E. and Karin, M., A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 1997. 388: 548554.
  • 25
    Swallow, M. M., Wallin, J. J. and Sha, W. C., B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha. Immunity 1999. 11: 423432.
  • 26
    Yoshimura, S., Bondeson, J., Foxwell, B. M., Brennan, F. M. and Feldmann, M., Effective antigen presentation by dendritic cells is NF-kappaB dependent: coordinate regulation of MHC, co-stimulatory molecules and cytokines. Int. Immunol. 2001. 13: 675683.
  • 27
    Erdman, S., Fox, J. G., Dangler, C. A., Feldman, D. and Horwitz, B. H., Typhlocolitis in NF-kappa B-deficient mice. J. Immunol. 2001. 166: 14431447.
  • 28
    Mazanet, M. M. and Hughes, C. C., B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis. J. Immunol. 2002. 169: 35813588.
  • 29
    Brown, J. A., Dorfman, D. M., Ma, F. R., Sullivan, E. L., Munoz, O., Wood, C. R., Greenfield, E. A. and Freeman, G. J., Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J. Immunol. 2003. 170: 12571266.
  • 30
    Petroff, M. G., Chen, L., Phillips, T. A., Azzola, D., Sedlmayr, P. and Hunt, J. S., B7 family molecules are favorably positioned at the human maternal-fetal interface. Biol. Reprod . 2002.
  • 31
    Nishimura, H., Agata, Y., Kawasaki, A., Sato, M., Imamura, S., Minato, N., Yagita, H., Nakano, T. and Honjo, T., Developmentally regulated expression of the PD-1 protein on the surface of double-negative (CD4CD8) thymocytes. Int. Immunol. 1996. 8: 773780.
  • 32
    Anderson, G., Jenkinson, E. J., Moore, N. C. and Owen, J. J., MHC class II-positive epithelium and mesenchyme cells are both required for T cell development in the thymus. Nature 1993. 362: 7073.
  • 33
    von Boehmer, H. and Hafen, K., Minor but not major histocompatibility antigens of thymus epithelium tolerize precursors of cytolytic T cells. Nature 1986. 320: 626628.
  • 34
    Hoffmann, M. W., Allison, J. and Miller, J. F., Tolerance induction by thymic medullary epithelium. Proc. Natl. Acad. Sci. USA 1992. 89: 25262530.
  • 35
    Nishimura, H., Honjo, T. and Minato, N., Facilitation of beta selection and modification of positive selection in the thymus of PD-1-deficient mice. J. Exp. Med. 2000. 191: 891898.
  • 36
    Iwai, Y., Okazaki, T., Nishimura, H., Kawasaki, A., Yagita, H. and Honjo, T., Microanatomical localization of PD-1 in human tonsils. Immunol. Lett. 2002. 83: 215220.
  • 37
    Stephens, L. A. and Kay, T. W., Pancreatic expression of B7 co-stimulatory molecules in the non-obese diabetic mouse. Int. Immunol. 1995. 7: 18851895.
  • 38
    Sainio-Pollanen, S., Rulli, M., Pollanen, P. and Simell, O., Appearance of cells expressing CD80 and CD86 costimulatory antigens in the pancreas of nonobese diabetic mice. Pancreas 1996. 13: 388394.
  • 39
    Issazadeh, S., Navikas, V., Schaub, M., Sayegh, M. and Khoury, S., Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo. J. Immunol. 1998. 161: 11041112.
  • 40
    Karandikar, N. J., Vanderlugt, C. L., Eagar, T., Tan, L., Bluestone, J. A. and Miller, S. D., Tissue-specific up-regulation of B7–1 expression and function during the course of murine relapsing experimental autoimmune encephalomyelitis. J. Immunol. 1998. 161: 192199.
  • 41
    Loke, P. and Allison, J. P., PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells. Proc. Natl. Acad. Sci. USA 2003. 100: 53365341.
  • 42
    Zhao, J., Freeman, G. J., Gray, G. S., Nadler, L. M. and Glimcher, L. H., A cell type-specific enhancer in the human B7.1 gene regulated by NF-kappaB. J. Exp. Med. 1996. 183: 777789.
  • 43
    Eppihimer, M. J., Gunn, J., Freeman, G. J., Greenfield, E. A., Chernova, T., Erickson, J. and Leonard, J. P., Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells. Microcirculation 2002. 9: 133145.
  • 44
    Dascher, C. C., Hiromatsu, K., Xiong, X., Sugita, M., Buhlmann, J. E., Dodge, I. L., Lee, S. Y., Roura-Mir, C., Watts, G. F., Roy, C. J., Behar, S. M., Clemens, D. L., Porcelli, S. A. and Brenner, M. B., Conservation of CD1 intracellular trafficking patterns between mammalian species. J. Immunol. 2002. 169: 69516958.